Logo image of ALMUN.PA

MUNIC (ALMUN.PA) Stock Fundamental Analysis

Europe - EPA:ALMUN - FR0013462231 - Common Stock

0.89 EUR
+0.02 (+2.53%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALMUN. ALMUN was compared to 28 industry peers in the Communications Equipment industry. Both the profitability and financial health of ALMUN have multiple concerns. ALMUN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALMUN had negative earnings in the past year.
ALMUN had a positive operating cash flow in the past year.
In the past 5 years ALMUN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALMUN reported negative operating cash flow in multiple years.
ALMUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALMUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

ALMUN has a Return On Assets (-6.82%) which is in line with its industry peers.
ALMUN's Return On Equity of -13.86% is in line compared to the rest of the industry. ALMUN outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA -6.82%
ROE -13.86%
ROIC N/A
ROA(3y)-2.63%
ROA(5y)-8.15%
ROE(3y)-5.44%
ROE(5y)-448.31%
ROIC(3y)N/A
ROIC(5y)N/A
ALMUN.PA Yearly ROA, ROE, ROICALMUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

Looking at the Gross Margin, with a value of 61.40%, ALMUN is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
In the last couple of years the Gross Margin of ALMUN has grown nicely.
The Profit Margin and Operating Margin are not available for ALMUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.95%
GM growth 5Y9.57%
ALMUN.PA Yearly Profit, Operating, Gross MarginsALMUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

ALMUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALMUN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ALMUN has been increased compared to 5 years ago.
Compared to 1 year ago, ALMUN has an improved debt to assets ratio.
ALMUN.PA Yearly Shares OutstandingALMUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALMUN.PA Yearly Total Debt VS Total AssetsALMUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.19, we must say that ALMUN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALMUN (0.19) is worse than 67.86% of its industry peers.
ALMUN has a debt to FCF ratio of 1.86. This is a very positive value and a sign of high solvency as it would only need 1.86 years to pay back of all of its debts.
ALMUN's Debt to FCF ratio of 1.86 is fine compared to the rest of the industry. ALMUN outperforms 71.43% of its industry peers.
ALMUN has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
ALMUN has a Debt to Equity ratio (0.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.86
Altman-Z 0.19
ROIC/WACCN/A
WACC6.09%
ALMUN.PA Yearly LT Debt VS Equity VS FCFALMUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

ALMUN has a Current Ratio of 1.25. This is a normal value and indicates that ALMUN is financially healthy and should not expect problems in meeting its short term obligations.
ALMUN's Current ratio of 1.25 is on the low side compared to the rest of the industry. ALMUN is outperformed by 75.00% of its industry peers.
ALMUN has a Quick Ratio of 1.25. This is a bad value and indicates that ALMUN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.88, ALMUN is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.88
ALMUN.PA Yearly Current Assets VS Current LiabilitesALMUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.31% over the past year.
The Revenue for ALMUN has decreased by -31.48% in the past year. This is quite bad
The Revenue has been decreasing by -0.61% on average over the past years.
EPS 1Y (TTM)20.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.74%
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y25.13%
Revenue growth 5Y-0.61%
Sales Q2Q%-29.55%

3.2 Future

ALMUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.11% yearly.
ALMUN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.72% yearly.
EPS Next Y150%
EPS Next 2Y58.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y21.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALMUN.PA Yearly Revenue VS EstimatesALMUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ALMUN.PA Yearly EPS VS EstimatesALMUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 0 -0.2 -0.4 -0.6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMUN. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 86.41, ALMUN can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALMUN is valued a bit more expensive than 67.86% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, ALMUN is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 86.41
ALMUN.PA Price Earnings VS Forward Price EarningsALMUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

ALMUN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALMUN is cheaper than 60.71% of the companies in the same industry.
ALMUN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALMUN is cheaper than 92.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.86
EV/EBITDA 10.77
ALMUN.PA Per share dataALMUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

ALMUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALMUN's earnings are expected to grow with 58.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.11%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALMUN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MUNIC

EPA:ALMUN (9/26/2025, 7:00:00 PM)

0.89

+0.02 (+2.53%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)N/A N/A
Earnings (Next)10-02 2025-10-02
Inst Owners1.69%
Inst Owner ChangeN/A
Ins Owners26.88%
Ins Owner ChangeN/A
Market Cap7.98M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 86.41
P/S 0.62
P/FCF 2.86
P/OCF 1.51
P/B 0.74
P/tB N/A
EV/EBITDA 10.77
EPS(TTM)-0.17
EYN/A
EPS(NY)0.01
Fwd EY1.16%
FCF(TTM)0.31
FCFY35.01%
OCF(TTM)0.59
OCFY66.4%
SpS1.44
BVpS1.21
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -13.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.4%
FCFM 21.68%
ROA(3y)-2.63%
ROA(5y)-8.15%
ROE(3y)-5.44%
ROE(5y)-448.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.95%
GM growth 5Y9.57%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.86
Debt/EBITDA 5.66
Cap/Depr 97.43%
Cap/Sales 19.44%
Interest Coverage N/A
Cash Conversion 678.26%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.88
Altman-Z 0.19
F-Score5
WACC6.09%
ROIC/WACCN/A
Cap/Depr(3y)373.79%
Cap/Depr(5y)531.76%
Cap/Sales(3y)17.82%
Cap/Sales(5y)20.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.74%
EPS Next Y150%
EPS Next 2Y58.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y25.13%
Revenue growth 5Y-0.61%
Sales Q2Q%-29.55%
Revenue Next Year50%
Revenue Next 2Y21.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2300%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y367.24%
OCF growth 3YN/A
OCF growth 5Y-13%